导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 19.26% | 212/1050 |
| 近一周 | 1.75% | 23/1104 |
| 近一月 | -3.83% | 504/1102 |
| 近一季 | 28.33% | 14/1092 |
| 近半年 | 22.34% | 118/1070 |
| 近一年 | 2.61% | 533/1018 |
| 近两年 | 64.49% | 405/926 |
| 近三年 | 31.48% | 388/833 |
| 成立以来 | 57.01% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
1.34% 395/1070 |
1.72% 665/1101 |
- - |
- - |
| 2025 | 24.94% 582/1065 |
4.92% 419/1014 |
11.11% 79/1038 |
26.89% 416/1050 |
-15.54% 990/1065 |
| 2024 | -12.88% 819/1011 |
-10.82% 790/960 |
-4.33% 593/983 |
12.71% 406/991 |
-9.41% 884/1011 |
| 2023 | -13.95% 476/952 |
-2.56% 736/880 |
-11.26% 793/895 |
3.01% 19/915 |
-3.39% 367/952 |
| 2022 | -18.43% 272/867 |
-14.00% 215/773 |
10.05% 267/806 |
-20.20% 758/845 |
8.00% 117/867 |
| 2021 | -3.59% 400/740 |
3.17% 76/580 |
21.46% 140/659 |
-8.18% 454/704 |
-16.21% 694/740 |
| 2020 | 78.27% 98/554 |
19.22% 10/419 |
35.59% 65/466 |
6.51% 333/517 |
3.54% 458/554 |
| 2019 | 58.93% 86/410 |
31.11% 310/1146 |
0.53% 280/1228 |
14.04% 50/390 |
5.73% 323/410 |
| 2018 | -22.88% 113/349 |
- - |
2.36% 41/990 |
-13.69% 924/1000 |
-16.50% 939/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.53% |
| 招商医药健康产业股票 | 2.5730 | 49.25% |
| 广发医药精选股票C | 1.2923 | 40.43% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 嘉实医疗保健股票 | 2.5780 | 38.47% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 中欧医疗创新股票A | 1.6444 | 34.01% |
| 中欧医疗创新股票C | 1.5481 | 33.74% |
| 嘉实医药健康股票C VS. 东吴新产业精选股票A(580008) |